190 related articles for article (PubMed ID: 21193172)
1. Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.
Nandam LS; Hester R; Wagner J; Cummins TD; Garner K; Dean AJ; Kim BN; Nathan PJ; Mattingley JB; Bellgrove MA
Biol Psychiatry; 2011 May; 69(9):902-4. PubMed ID: 21193172
[TBL] [Abstract][Full Text] [Related]
2. Monoaminergic modulation of behavioural and electrophysiological indices of error processing.
Barnes JJ; O'Connell RG; Nandam LS; Dean AJ; Bellgrove MA
Psychopharmacology (Berl); 2014 Jan; 231(2):379-92. PubMed ID: 23995299
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
Bédard AC; Stein MA; Halperin JM; Krone B; Rajwan E; Newcorn JH
J Child Psychol Psychiatry; 2015 Jan; 56(1):40-8. PubMed ID: 24942409
[TBL] [Abstract][Full Text] [Related]
4. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.
Bari A; Eagle DM; Mar AC; Robinson ES; Robbins TW
Psychopharmacology (Berl); 2009 Aug; 205(2):273-83. PubMed ID: 19404616
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical enhancement of conscious error awareness.
Hester R; Nandam LS; O'Connell RG; Wagner J; Strudwick M; Nathan PJ; Mattingley JB; Bellgrove MA
J Neurosci; 2012 Feb; 32(8):2619-27. PubMed ID: 22357846
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the Attention Network Test.
Kratz O; Studer P; Baack J; Malcherek S; Erbe K; Moll GH; Heinrich H
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):81-9. PubMed ID: 22227291
[TBL] [Abstract][Full Text] [Related]
7. Animal model of methylphenidate's long-term memory-enhancing effects.
Carmack SA; Howell KK; Rasaei K; Reas ET; Anagnostaras SG
Learn Mem; 2014 Jan; 21(2):82-9. PubMed ID: 24434869
[TBL] [Abstract][Full Text] [Related]
8. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer MJ; Simmons A; Rubia K
Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018
[TBL] [Abstract][Full Text] [Related]
9. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.
Chamberlain SR; Hampshire A; Müller U; Rubia K; Del Campo N; Craig K; Regenthal R; Suckling J; Roiser JP; Grant JE; Bullmore ET; Robbins TW; Sahakian BJ
Biol Psychiatry; 2009 Apr; 65(7):550-5. PubMed ID: 19026407
[TBL] [Abstract][Full Text] [Related]
10. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
[TBL] [Abstract][Full Text] [Related]
11. Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.
Baarendse PJ; Vanderschuren LJ
Psychopharmacology (Berl); 2012 Jan; 219(2):313-26. PubMed ID: 22134476
[TBL] [Abstract][Full Text] [Related]
12. Atomoxetine increases salivary cortisol in healthy volunteers.
Chamberlain SR; Müller U; Cleary S; Robbins TW; Sahakian BJ
J Psychopharmacol; 2007 Jul; 21(5):545-9. PubMed ID: 17446206
[TBL] [Abstract][Full Text] [Related]
13. Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks.
Nandam LS; Hester R; Bellgrove MA
Neuropsychologia; 2014 Apr; 56():263-70. PubMed ID: 24513025
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.
Chamberlain SR; Del Campo N; Dowson J; Müller U; Clark L; Robbins TW; Sahakian BJ
Biol Psychiatry; 2007 Nov; 62(9):977-84. PubMed ID: 17644072
[TBL] [Abstract][Full Text] [Related]
16. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
[TBL] [Abstract][Full Text] [Related]
17. Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
Sangal RB; Owens J; Allen AJ; Sutton V; Schuh K; Kelsey D
Sleep; 2006 Dec; 29(12):1573-85. PubMed ID: 17252888
[TBL] [Abstract][Full Text] [Related]
18. Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.
Harvey RC; Jordan CJ; Tassin DH; Moody KR; Dwoskin LP; Kantak KM
Behav Brain Res; 2013 May; 244():38-47. PubMed ID: 23376704
[TBL] [Abstract][Full Text] [Related]
19. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
Kowalczyk OS; Cubillo AI; Smith A; Barrett N; Giampietro V; Brammer M; Simmons A; Rubia K
Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
